- Home
- PRCH vs DCTH Comparison
PRCH vs DCTH Comparison
Compare PRCH & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCH
- DCTH
- Stock Information
- Founded
- PRCH 2012
- DCTH 1988
- Country
- PRCH United States
- DCTH United States
- Employees
- PRCH N/A
- DCTH 76
- Industry
- PRCH Computer Software: Prepackaged Software
- DCTH Medical/Dental Instruments
- Sector
- PRCH Technology
- DCTH Health Care
- Exchange
- PRCH Nasdaq
- DCTH Nasdaq
- Market Cap
- PRCH 656.3M
- DCTH 426.3M
- IPO Year
- PRCH N/A
- DCTH N/A
- Fundamental
- Price
- PRCH $12.46
- DCTH $11.52
- Analyst Decision
- PRCH Strong Buy
- DCTH Strong Buy
- Analyst Count
- PRCH 8
- DCTH 4
- Target Price
- PRCH $10.28
- DCTH $24.00
- AVG Volume (30 Days)
- PRCH 2.2M
- DCTH 873.0K
- Earning Date
- PRCH 08-05-2025
- DCTH 08-04-2025
- Dividend Yield
- PRCH N/A
- DCTH N/A
- EPS Growth
- PRCH N/A
- DCTH N/A
- EPS
- PRCH N/A
- DCTH N/A
- Revenue
- PRCH $427,150,000.00
- DCTH $53,850,000.00
- Revenue This Year
- PRCH $4.28
- DCTH $155.42
- Revenue Next Year
- PRCH $12.88
- DCTH $37.93
- P/E Ratio
- PRCH N/A
- DCTH N/A
- Revenue Growth
- PRCH N/A
- DCTH 1068.87
- 52 Week Low
- PRCH $1.05
- DCTH $7.17
- 52 Week High
- PRCH $13.59
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- PRCH 60.03
- DCTH 32.83
- Support Level
- PRCH $12.13
- DCTH $12.11
- Resistance Level
- PRCH $13.59
- DCTH $14.15
- Average True Range (ATR)
- PRCH 0.86
- DCTH 0.57
- MACD
- PRCH 0.04
- DCTH -0.16
- Stochastic Oscillator
- PRCH 69.16
- DCTH 9.67
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.